Canadian application, no grantCanada
Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor
CA 2369250 A1 · Owner: Hoi-Tao Wong, Andrew · Inventors: Hoi-Tao Wong, Andrew; Koromilas, Antonis E.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A STAT1 mutant which is unable to bind PKR is provided. The mutant is useful to enhance endogenous anti-viral and anti-proliferative activity in mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 24, 2002
GrantedNo grant recorded
Term endedJanuary 24, 2022
Patent numberCA 2369250 A1
Classification (IPC)C12N7/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.